Professor Tess Cramond joined the Queensland anaesthesia workforce in 1958, and contributed to high standards of clinical practice, pain management, training, scholarship and research. Evidence of her excellence, within the clinical, political and community spheres was recognised by multiple awards. Though deceased in 2015, she remains a role model for all physicians, using her expert knowledge, technical skills, clinical reasoning, emotions and values for the benefit of the individuals and community which she served.
O'Rourke BT.The Elkington Oration “Not the Broad Street Pump” delivered to the Queensland Society of Health at the Edwin Tooth lecture theatre Royal Brisbane Hospital on the occasion of the 25th annual meeting, 1st September 1982. Printed in: “Tess Cramond, Clinician, Academic and Humanitarian”, Festschrift book (Ed. Bronwyn Williams), 2009.
5.
SafarP.From back-pressure arm-lift to mouth-to-mouth control of airway and beyond. In: SafarP., ElamJ.O., eds. Advances in cardiopulmonary resuscitation.New York: Springer-Verlag, 1977; 266–275.
6.
Council on Medical Physics (USA).Symposium on Mouth-To-Mouth Resuscitation (Expired Air Inflation). Report to the Council. JAMA1958; 167: 317–341.
7.
RankinR. Quoted from eulogy delivered on 8/1/2016 at Tess's funeral by Ron Rankin AM, Immediate Past President Surf Life Saving Australia, Past President Surf Life Saving Queensland, 2016.
ThomsonE.“Future needs for medical education in Queensland”. Report of committee to enquire into future needs and training for medical practice in Queensland. Medical Board of Queensland, Brisbane, 1981.
10.
CramondT.“A privilege and a responsibility-the challenge of terminal care”. University College of Southern Queensland. The Second Concannon Oration, Toowomba Queensland, 4th October 1989.
11.
BrophyT.“The Challenge of Terminal Care”. President's address delivered at the Adjourned Annual Meeting of the Queensland branch of the Australian Medical Association. Brisbane Grammar School, 19th June, 1982 Paper held by AMAQ Archives Queensland Branch AMA.
12.
SmithM.T., WattJ.A., CramondT.Morphine-3-glucuronide—a potent antagonist of morphine analgesia. Life Sci1990; 47: 579–585.
13.
BartlettS.E., CramondT., SmithM.T.The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. Life Sci1994; 54: 687–694.
LaaksoL., RichardsonC., CramondT.Quality of light—is laser necessary for effective photobiostimulation?Aust J Physiother1993; 39: 87–92.
16.
LeowK.P., SmithM.T., WattJ.A., WilliamsB.E., CramondT.Comparative oxycodone pharmacokinetics in humans after intravenous, oral, and rectal administration. Ther Drug Monit1992; 14: 479–484.
17.
LeowK.P., SmithM.T., WilliamsB., CramondT.Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clin Pharmacol Ther1992; 52: 487–495.
18.
SmithM.T., WattJ.A., MappG.P., CramondT.Quantitation of oxycodone in human plasma using high-performance liquid chromatography with electrochemical detection. Ther Drug Monit1991; 13: 126–130.
19.
WrightA.W., LawrenceJ.A., IuM., CramondT., SmithM.T.Solid-phase extraction method with high-performance liquid chromatography and electrochemical detection for the quantitative analysis of oxycodone in human plasma. J Chromatogr B Biomed Sci Appl1998; 712: 169–175.
20.
LeowK.P., CramondT., SmithM.T.Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesth Analg1995; 80: 296–302.
21.
WrightA.W., WattJ.A., KennedyM., CramondT., SmithM.T.Quantitation of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma and cerebrospinal fluid using solid-phase extraction and high-performance liquid chromatography with electrochemical detection. Ther Drug Monit1994; 16: 200–208.
22.
LeowK.P., WrightA.W., CramondT., SmithM.T.Determination of the serum protein binding of oxycodone and morphine using ultrafiltration. Ther Drug Monit1993; 15: 440–447.
23.
NissenL.M., TettS.E., CramondT., WilliamsB., SmithM.T.Opioid analgesic prescribing and use—an audit of analgesic prescribing by general practitioners and The Multidisciplinary Pain Centre at Royal Brisbane Hospital. Br J Clin Pharmacol2001; 52: 693–698.
24.
McCahonS., StrongJ., SharryR., CramondT.Self-report and pain behavior among patients with chronic pain. Clin J Pain2005; 21: 223–231.
25.
NissenL.M., TettS.E., CramondT., WilliamsB., SmithM.T.Opioid analgesic prescribing and use—an audit of analgesic prescribing by general practitioners and The Multidisciplinary Pain Centre at Royal Brisbane Hospital. Br J Clin Pharmacol2001; 52: 693–698.
26.
KeatesH.L., CramondT., SmithM.T.Intraarticular and periarticular opioid binding in inflamed tissue in experimental canine arthritis. Anesth Analg1999; 89: 409–415.
27.
SmithM.T., WrightA.W., WilliamsB.E., StuartG., CramondT.Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management. Anesth Analg1999; 88: 109–116.
28.
AllenR.K., CramondT., LennonD., WaterhouseM.A.Retrospective study of chest pain in benign asbestos pleural disease. Pain Med2011; 12: 1303–1308.
29.
GrayP., KirbyJ., SmithM.T., CabotP.J., WilliamsB., DoeckeJ., CramondT.Pregabalin in severe burn injury pain: a double-blind, randomised placebo-controlled trial. Pain2011; 152: 1279–1288.
30.
GrayP., WilliamsB., CramondT.Successful use of gabapentin in acute pain management following burn injury: a case series. Pain Med2008; 9: 371–376.
31.
MacleodA.G., AshfordB., VoltzM., WilliamsB., CramondT., GortaL., SimpsonJ.M.Paracetamol versus paracetamol-codeine in the treatment of post-operative dental pain: a randomized, double-blind, prospective trial. Aust Dent J2002; 47: 147–151.
32.
CabotP.J., CramondT., SmithM.T.Morphine has a dual concentration-dependent effect on K(+)-evoked substance P release from rat peripheral airways. Pulm Pharmacol Ther1997; 10: 215–221.
33.
CabotP.J., CramondT., SmithM.T.Quantitative autoradiography of peripheral opioid binding sites in rat lung. Eur J Pharmacol1996; 310: 47–53.
34.
CabotP.J., DoddP.R., CramondT., SmithM.T.Characterization of non-conventional opioid binding sites in rat and human lung. Eur J Pharmacol1994; 268: 247–255.
35.
CramondT., StuartG.J.Intraventricular morphine for intractable pain of advanced cancer. J Pain Symptom Manage1993; 8: 465–473.
36.
StuartG., CramondT.Role of percutaneous cervical cordotomy for pain of malignant origin. Med J Aust1993; 158: 667–670.
37.
CramondT.The problems of resuscitation. Part 2: The efficacy of resuscitation. Aust Fam Physician1987; 16: 1314–1316; 1318–1319.
38.
CramondT.The problems of resuscitation. Part 1: Modern dilemmas. Aust Fam Physician1987; 16: 1203–1205; 1207–1209.
CramondT.Curriculum Vitae2009; quoted in “Tess Cramond, Clinician, Academic and Humanitarian” 2009 Festschrift book, including papers presented, tributes, a history of her life's work and selected research papers. Compiled and edited by Bronwyn Williams, 2009.
45.
BrophyT.“President's address”AMA News Bulletin Queensland Branch.1981; 20: 8 Paper held by AMAQ Archives Queensland Branch AMA, 1981.
